News

This week President Donald Trump nominated attorney Jonathan Berry to be the next solicitor of the Department of Labor (DOL).

Last week, the U.S. Embassy in Paris issued a letter and certification form to multiple French companies requiring companies that serve the U.S. Government to certify their compliance with U.S. federal anti-discrimination laws.

As a follow-up to our blog post in February about the Securities and Exchange Commission’s (SEC) pause in defending its Climate Disclosure Rules, on March 27, the SEC notified the U.S. Court of Appeals for the Eighth Circuit that it was officially withdrawing its defense of those rules....

The UK Financial Conduct Authority (FCA) has unveiled its ambitious strategy for 2025-2030, with growth identified as a cornerstone of its forward-looking approach.

We previously reported on the groundbreaking AI Fair Use ruling in the Thomson Reuters Ross Intelligence case, where the court found that based on the facts of this case fair use was not a defense. Ross Intelligence moved, pursuant to 28 U.S.C.

The tariffs enacted and proposed by the Trump administration have created a cause for concern among industries worldwide, and the construction sector is no exception.

On March 12, 2025, the Securities and Exchange Commission issued a significant No-Action Letter, providing clarity on how issuers can satisfy the “reasonable steps” requirement for verifying accredited investor status in Rule 506(c) Regulation D offerings.

Important Takeaways from the updated 2025 SIAC Rules: - The seventh edition of the Singapore International Centre’s Arbitration Rules (“SIAC Rules 2025”)1 came into effect on January 1, 2025, nine years after the last iteration.

On March 31, 2025, members of the U.S. House of Representatives Committee on Financial Services sent a letter to Mark Uyeda, Acting Chairman of the U.S. Securities and Exchange Commission.

On March 31, 2025, the US District Court for the Eastern District of Texas struck down the US Food and Drug Administration’s (FDA) final rule under which FDA would have started regulating most laboratory-developed tests (LDTs) as medical devices on May 6, 2025....

Pages